UPDATE: This podcast was recorded in May of 2021. We are sad to report that Dr. Ralf Kleef passed away December 6, 2021. He was a dear friend and colleague of Dr. Moss and will be greatly missed.

Original episode description:

Dr. Ralf Kleef is one of the world's leading experts in Immunotherapy. In this episode of The Moss Report Podcast, Dr. Moss speaks with Dr. Kleef about his work with Integrative Immune Oncology. They also discuss Dr. Kleef's paper evaluating the outcome of all of his patients receiving treatment over a 5-year period. This peer-reviewed paper is a groundbreaking accomplishment in the field of alternative medicine and the results have made waves in the cancer field.

Dr. Kleef's involvement with immunotherapy goes back 30 years and includes time at the National Institute of Health, Memorial Sloan-Kettering, and working directly with major contributors to the field, such as Helen Coley-Nauts. Dr. Kleef is also heavily featured in the recent film "Immunotherapy: The Battle Within."

In this episode of The Moss Report Podcast, Dr. Michael Gonzalez of the University of Puerto Rico shares his enthusiasm for the intersections of cancer and Quantum physics. In his conversation with Dr. Moss, they discuss a holistic approach to cancer treatment including consideration of Vitamin C, energy levels, and metabolism.

Dr. Michael J. Gonzalez, BS, MS, MHSN, DSc, NMD, PhD, FANMA, FACN is a Professor at the Nutrition Program, School of Public Health in the Medical Sciences Campus, University of Puerto Rico and Adjunct faculty at the Universidad Central del Caribe School of Medicine. Dr. Gonzalez is a Fellow of the American College of Nutrition and has authored over 250 scientific publications. He has obtained several research awards for his work on Nutrition, Supplementation, and Cancer.

Doctor Gonzalez is a founder of InBioMed, leaders in the development of non-toxic chemotherapy treatments for cancer. The findings of their work with Intravenous Vitamin C as an anti-cancer agent, published in 2002, were confirmed by the NIH in 2005. They published the first Phase-I clinical study utilizing Intravenous Vitamin C for the treatment of terminal cancer patients in 2005, and also published in 2005, the most comprehensive review on Vitamin C and Cancer, as a follow-up on the work of two times Nobel Laureate, Dr. Linus C. Pauling. He has brought many new concepts into the scientific field, such as the Bio-energetic theory of carcinogenesis, the physiological modulation concept, the systemic saturation phenomenon of intravenous vitamin C, the metabolic and mitochondrial correction model for disease treatment and prevention. Dr. Gonzalez was inducted into the International Hall of fame of Orthomolecular Medicine in April 2016. He is one of the first Latino and Puerto Rican to be inducted into the International Hall of fame of Orthomolecular Medicine.

Dr. Gonzalez is studying quantum physics to better understand energy and information, this includes laser therapy, exosomes, mitochondrial enhancement, and stem cells as therapeutic tools for degenerative diseases

In this episode of The Moss Report Podcast, Dr. Moss speaks with Dr. Francisco Contreras and Daniel Kennedy about the Oasis of Hope clinic located in Tijuana. In this interview, they discuss the history of the clinic, their current approach, and where they'd like to see cancer treatments headed in the future.

Oasis of Hope, the oldest CAM clinic for cancer in Mexico, has made headlines for their use of Laetrile, a treatment derived from apricot kernels that has been the subject of much controversy in the US. The clinic also utilizes chemotherapy, dendritic cell vaccines, immune therapies as well as targeted metabolic therapies.

In this episode of The Moss Report Podcast, Doug and Rochelle Burnett of Des Moines, Iowa share their journey through a cancer diagnosis.

Doug was diagnosed with Stage III cancer of the GE Junction in March of 2019. Based in Iowa, they were given the treatment plan of radiation, chemo, and eventually surgery. Pursuing other options, he and Rochelle did research on what else was out there. They ended up at MD Anderson in Houston, Texas where Doug was given a grim prognosis. Stage IV and without much hope, the doctors didn't have much to say to him in terms of working towards health.

With some help from Dr. Moss, they found Dr. Robert Nagourney of the Nagourney Institute. Dr. Nagourney prescribed a custom chemo cocktail, which, when combined, saw Doug's chances of survival greatly improved. Add to this some diet and lifestyle changes and a healthy helping of love, support, optimism, and determination, Doug Burnett is surviving, and thriving, well beyond any previous prognosis.

In this episode of The Moss Report Podcast, Dr. Ralph W. Moss speaks with Dr. Nasha Winters. Dr. Winters shares her experiences about her ovarian cancer, her life as a student, and then as a practitioner. She discusses how her personal struggle motivated her to help build a new hospital and research institute, whose mission is to offer metabolic oncology and advanced integrative therapies.

In this episode of The Moss Report Podcast, Ralph W. Moss speaks with Dr. Robert Nagourney about his well-documented approach to precision oncology. Nagourney's strategy takes a step away from genetic sequencing. By taking a biopsy of a tumor, he claims to be able to deduce what treatments will be effective for an individual. Also in this episode is a discussion about repurposed drugs for cancer treatment, including the use of Metformin.

Robert A. Nagourney, MD, is Medical and Laboratory Director of The Nagourney Cancer Institute in Long Beach, California, and an Associate Clinical Professor, at the University of California Irvine. He is board-certified in internal medicine, medical oncology, and hematology.

Learn more about Dr. Nagourney's work at www.nagourneycancerinstitute.com/

Learn more about Dr. Moss's work at

www.mossreports.com

In this episode of The Moss Report Podcast, Mary Hardy, MD, and David Wales, talk with our host, Ralph W. Moss, Ph.D. about recent research on an unusual treatment: fermented wheat germ extract (FWGE).

Recent research has shown FWGE can reduce the abnormal metabolism of cancer cells. This raises the prospect that FWGE might heal cancer cells by reversing the "Warburg Effect," thus converting a glucose-fermenting cell back into a normal cell.

The research into wheat germ has a long history and a promising future, as scientific papers show verifiable results and FWGE becomes more widely available.

Mary Hardy, MD, is board-certified in internal medicine and a specialist in botanical and integrative medicine. She has been combining complementary and alternative therapies with Western medicine for over thirty years in both her clinical practice and research projects. She also has a long-standing interest in patients who have shown exceptional responses during cancer care.

In this episode of The Moss Report Podcast, Dr. Moss speaks with Abdul Slocum, MD, one of the founders of the Chemothermia Oncology Center in Istanbul, Turkey. Dr. Moss visited this clinic in 2017 and was intrigued by their approach to cancer treatment. Discover the history and approach of Chemothermia, the work of Dr. Berkarda, and their latest integrative approaches. Find out about the applications of Metabolically Supported Chemotherapy, and how this clinic uses diet, nutrients, hyperthermia, and more in the treatment of cancer patients.

Dr. Slocum comes from an integrative medical background and has a particular interest in helping patients suffering from cancer and exploring new ways of addressing the disease. He has worked with the Chemothermia team on the development and application of conventional as well as innovative treatment modalities for oncology and has particular responsibility for the clinic's international patients.

Thomas N. Seyfried, Ph.D., is the author of "Cancer as a Metabolic Disease," a work that has revolutionized our understanding of cancer metabolism.

Prof. Seyfried's 45 years of laboratory work has revived Otto Warburg's thesis that cancer is a disease of the mitochondria, the energy-generating part of the cell. Prof. Seyfried has devised unique animal models to explain the processes of inflammation, blood vessel formation, and lipid biochemistry. He is also mainly responsible for the renewed interest in calorie restriction, fasting, and ketogenic diets. In the process, he has waged war against the faltering dogma that cancer is a genetic disease.

For more information, visit themossreport.com

Author of "Keto For Cancer" and head of Dietary Therapies, LLC, Miriam Kalamian is a nutrition consultant, educator, author, and speaker with a passion for ketogenic therapies.

She earned her Master's in Education from Smith College and her Master's in Human Nutrition from Eastern Michigan University and is board certified in nutrition by the Board for Certification of Nutrition Specialists (CNS). Miriam was inspired by the groundbreaking work of Thomas Seyfried, who introduced her to the ketogenic diet for cancer a few years into her young son's treatment for a devastating brain tumor.

Now, in her book Keto for Cancer, Miriam demystifies the diet for those who want to apply this nutritional strategy as part of a metabolic approach to cancer.